Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-09-05 Purchase | 2023-09-06 5:11 pm | ZEVRA THERAPEUTICS INC. | ZVRA | Schafer Joshua CCO & EVP, Bus. Development | 500 | $5.129 | $2,565 | 3,500 (Direct) | View |
2023-09-06 Purchase | 2023-09-06 5:11 pm | ZEVRA THERAPEUTICS INC. | ZVRA | Clifton R. LaDuane CFO, Secretary & Treasurer | 1,000 | $4.9591 | $4,959 | 15,309 (Direct) | View |
2023-09-05 Purchase | 2023-09-06 4:40 pm | ZEVRA THERAPEUTICS INC. | ZVRA | Bode John B Director | 10,000 | $5.1333 | $51,333 | 20,000 (Direct) | View |
2023-09-06 Purchase | 2023-09-06 4:39 pm | ZEVRA THERAPEUTICS INC. | ZVRA | Anderson Thomas Director | 10,000 | $4.8764 | $48,764 | 10,000 (Direct) | View |
2023-05-19 Purchase | 2023-06-30 4:14 pm | ZEVRA THERAPEUTICS INC. | ZVRA | Schafer Joshua CCO & EVP, Bus. Development | 1,000 | $5.4157 | $5,416 | 3,000 (Direct) | View |
2023-06-23 Purchase | 2023-06-26 4:19 pm | ZEVRA THERAPEUTICS INC. | ZVRA | Watton Corey Michael Director | 275 | $5.9479 | $1,636 | 1,000 (Direct) | View |
2023-06-09 Purchase | 2023-06-13 8:35 pm | ZEVRA THERAPEUTICS INC. | ZVRA | Watton Corey Michael Director | 325 | $5.52 | $1,794 | 1,125 (Direct) | View |
2023-05-30 Purchase | 2023-05-31 11:34 am | ZEVRA THERAPEUTICS INC. | ZVRA | Watton Corey Michael Director | 400 | $5.1053 | $2,042 | 400 (Direct) | View |
2023-05-18 Purchase | 2023-05-19 5:53 pm | ZEVRA THERAPEUTICS INC. | ZVRA | Bode John B Director | 10,000 | $5.0418 | $50,418 | 10,000 (Direct) | View |
2023-05-18 Purchase | 2023-05-18 4:56 pm | ZEVRA THERAPEUTICS INC. | ZVRA | Clifton R. LaDuane CFO, Secretary & Treasurer | 2,740 | $4.9496 | $13,562 | 13,742 (Direct) | View |
2023-03-17 Purchase | 2023-03-21 4:32 pm | ZEVRA THERAPEUTICS INC. | ZVRA | SEYMOUR TAMARA A Director | 519 | $4.8215 | $2,502 | 719 (Direct) | View |
2023-03-14 Purchase | 2023-03-15 8:14 pm | ZEVRA THERAPEUTICS INC. | ZVRA | Schafer Joshua CCO & EVP, Bus. Development | 2,000 | $4.6089 | $9,218 | 2,000 (Direct) | View |
2023-03-09 Purchase | 2023-03-13 07:59 am | ZEVRA THERAPEUTICS INC. | ZVRA | Plooster Matthew R Director | 11,000 | $4.1953 | $46,148 | 20,101 (Indirect Direct) | View |
2023-03-10 Purchase | 2023-03-13 07:57 am | ZEVRA THERAPEUTICS INC. | ZVRA | Sangiovanni Timothy J. SVP, Corporate Controller | 1,200 | $4.1393 | $4,967 | 4,449 (Direct) | View |
2023-03-10 Purchase | 2023-03-13 07:56 am | ZEVRA THERAPEUTICS INC. | ZVRA | Clifton R. LaDuane CFO, Secretary & Treasurer | 1,725 | $4.15 | $7,159 | 11,002 (Direct) | View |
2023-03-09 Purchase | 2023-03-13 07:54 am | ZEVRA THERAPEUTICS INC. | ZVRA | Tierney David S Director | 5,000 | $4.1463 | $20,732 | 10,835 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-01-31 Option Award | 2024-02-02 9:22 pm | N/A N/A | ZEVRA THERAPEUTICS INC. | ZVRA | Schafer Joshua CCO & EVP, Bus. Development | 106,000 | $0 | 106,000 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 8:17 pm | N/A N/A | ZEVRA THERAPEUTICS INC. | ZVRA | Sangiovanni Timothy J. SVP, Corporate Controller | 35,000 | $0 | 35,000 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 8:14 pm | N/A N/A | ZEVRA THERAPEUTICS INC. | ZVRA | Mickle Christal M M Chief Development Officer | 77,000 | $0 | 77,000 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 8:13 pm | N/A N/A | ZEVRA THERAPEUTICS INC. | ZVRA | Guenther Sven Chief Scientific Officer | 79,000 | $0 | 79,000 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 8:11 pm | N/A N/A | ZEVRA THERAPEUTICS INC. | ZVRA | Clifton R. LaDuane CFO, Secretary & Treasurer | 130,000 | $0 | 130,000 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 8:10 pm | N/A N/A | ZEVRA THERAPEUTICS INC. | ZVRA | McFarlane Neil F. President and CEO | 700,000 | $0 | 700,000 (Direct) | View |
2024-01-20 Option Award | 2024-02-02 8:08 pm | N/A 2034-01-19 | ZEVRA THERAPEUTICS INC. | ZVRA | Shih Alvin Director | 58,800 | $0 | 58,800 (Direct) | View |
2023-10-10 Option Award | 2023-10-11 4:33 pm | N/A 2033-10-09 | ZEVRA THERAPEUTICS INC. | ZVRA | McFarlane Neil F. President and CEO | 800,000 | $0 | 800,000 (Direct) | View |
2023-08-07 Option Award | 2023-08-25 4:19 pm | N/A 2033-08-06 | ZEVRA THERAPEUTICS INC. | ZVRA | Anderson Thomas Director | 58,800 | $0 | 58,800 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 4:33 pm | N/A 2033-05-30 | ZEVRA THERAPEUTICS INC. | ZVRA | FAVORITO TAMARA A Director | 10,000 | $0 | 10,000 (Direct) | View |
2023-05-03 Option Award | 2023-05-11 8:02 pm | N/A 2033-05-02 | ZEVRA THERAPEUTICS INC. | ZVRA | Calder Douglas W Director | 58,800 | $0 | 58,800 (Direct) | View |
2023-05-03 Option Award | 2023-05-08 9:55 pm | N/A 2033-05-02 | ZEVRA THERAPEUTICS INC. | ZVRA | Watton Corey Michael Director | 58,800 | $0 | 58,800 (Direct) | View |
2023-04-25 Option Award | 2023-05-08 9:54 pm | N/A 2033-04-24 | ZEVRA THERAPEUTICS INC. | ZVRA | Saluri Joseph Director | 39,200 | $0 | 39,200 (Direct) | View |
2023-04-25 Option Award | 2023-05-08 9:53 pm | N/A 2033-04-24 | ZEVRA THERAPEUTICS INC. | ZVRA | Plooster Matthew R Director | 49,200 | $0 | 49,200 (Direct) | View |
2023-04-25 Option Award | 2023-05-08 9:51 pm | N/A 2033-04-24 | ZEVRA THERAPEUTICS INC. | ZVRA | FAVORITO TAMARA A Director | 39,200 | $0 | 39,200 (Direct) | View |
2023-04-25 Option Award | 2023-05-08 9:50 pm | N/A 2033-04-24 | ZEVRA THERAPEUTICS INC. | ZVRA | DIXON WENDY L Director | 58,800 | $0 | 58,800 (Direct) | View |
2023-05-03 Option Award | 2023-05-08 9:44 pm | N/A 2033-05-02 | ZEVRA THERAPEUTICS INC. | ZVRA | Bode John B Director | 58,800 | $0 | 58,800 (Direct) | View |